PMC:7696151 / 1061-1215
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 28 | 13-16 | Chemical | denotes | HCQ | MESH:D006886 |
| 38 | 62-81 | Disease | denotes | autoimmune diseases | MESH:D001327 |
| 39 | 90-110 | Disease | denotes | rheumatoid arthritis | MESH:D001172 |
| 40 | 112-131 | Disease | denotes | lupus erythematosus | MESH:D008180 |
| 41 | 137-153 | Disease | denotes | Sjögren syndrome | MESH:D012859 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 62-81 | Phenotype | denotes | autoimmune diseases | http://purl.obolibrary.org/obo/HP_0002960 |
| T2 | 90-110 | Phenotype | denotes | rheumatoid arthritis | http://purl.obolibrary.org/obo/HP_0001370 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T10 | 0-154 | Sentence | denotes | By contrast, HCQ arises as a first-line treatment in managing autoimmune diseases such as rheumatoid arthritis, lupus erythematosus, and Sjögren syndrome. |